Autism genetic testing: A qualitative study of awareness, attitudes, and experiences among parents of children with autism spectrum disorders

Genetics in Medicine

Volumn 15, Issue 4, 2013, Pages 274-281

  Chen, Lei Shih ^a   Xu, Lei ^a   Huang, Tse Yang ^b   Dhar, Shweta U ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

attitude; autism spectrum disorders; awareness; genetic testing; parents

Indexed keywords

ARTICLE; ASIAN; AUTISM; AWARENESS; CHILDHOOD DISEASE; CLINICAL ARTICLE; EARLY INTERVENTION; ETHNIC DIFFERENCE; FAMILY CONFLICT; FAMILY PLANNING; FEMALE; GENETIC SCREENING; GENETIC SERVICE; HEALTH CARE ACCESS; HEALTH EDUCATION; HEALTH INSURANCE; HUMAN; MALE; MOTIVATION; PARENTAL ATTITUDE; PERSONAL EXPERIENCE; PROFESSIONAL COMPETENCE; QUALITATIVE RESEARCH; RACE DIFFERENCE; SEMI STRUCTURED INTERVIEW; SOCIAL STATUS;

EID: 84875950569     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.145     Document Type: Article

References (40)

1. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008;9:341-355.
2. Johnson HM, Gaitanis J, Morrow EM. Genetics in autism diagnosis: adding molecular subtypes to neurobehavioral diagnoses. Med Health R I 2011;94:124-126.
3. Miller DT. Genetic testing for autism: recent advances and clinical implications. Expert Rev Mol Diagn 2010;10:837-840.
4. Myers SM, Johnson CP; American Academy of Pediatrics Council on Children With Disabilities. Management of children with autism spectrum disorders. Pediatrics 2007;120:1162-1182.
5. Schaefer GB, Mendelsohn NJ; Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 2008;10:301-305.
6. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-764.
7. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007;316:445-449.
8. Shen Y, Dies KA, Holm IA, et al.; Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010;125:e727-e735.
9. Roesser J. Diagnostic yield of genetic testing in children diagnosed with autism spectrum disorders at a regional referral center. Clin Pediatr (Phila) 2011;50:834-843.
10. Reddy KS. Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Med Genet 2005;6:3.
11. Gurrieri F. Working up autism: the practical role of medical genetics. Am J Med Genet C Semin Med Genet 2012;160C:104-110.
12. O'Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011;43:585-589.
13. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011;474:380-384.
14. Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and autism. N Engl J Med 2012;366:733-743.
15. Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000;55:468-479.
16. Marchant GE, Robert JS. Genetic testing for autism predispostion: ethical, legal, and soical challenges. Houst J Health Law Policy 2009:203-235.
17. Jordan BR, Tsai DF. Whole-genome association studies for multigenic diseases: ethical dilemmas arising from commercialization-the case of genetic testing for autism. J Med Ethics 2010;36:440-444.
18. Skinner D, Sparkman KL, Bailey DB Jr. Screening for Fragile X Syndrome: parent attitudes and perspectives. Genet Med 2003;5:378-384.
19. Whitman T. The Development of Autism: A Self-regulatory Perspective. London, England: Jessica Kingsley Publishers; 2004.
20. Campbell E, Ross LF. Parental attitudes and beliefs regarding the genetic testing of children. Community Genet 2005;8:94-102.
21. Lincoln YS, Guba EG. Naturalistic Inquiry.Thousand Oaks, CA: Sage Publications;1985.
22. Selkirk CG, McCarthy Veach P, Lian F, Schimmenti L, LeRoy BS. Parents' perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: Recommendations for genetic counselors. J Genet Couns 2009;18:507-519.
23. Miquel-Verges F, Woods SL, Aucott SW, Boss RD, Sulpar LJ, Donohue PK. Prenatal consultation with a neonatologist for congenital anomalies: parental perceptions. Pediatrics 2009;124:e573-e579.
24. Mercer L, Creighton S, Holden JJ, Lewis ME. Parental perspectives on the causes of an autism spectrum disorder in their children. J Genet Couns 2006;15:41-50.
25. Barbara AB. The role of qualitative research in medicial genetics: listening to the voices of our patients. Am J Med Genet. Part A 2008;146A:3132-3135
26. Genetic Information Nondiscrimination Act (GINA) of 2008. 〈http://www.gpo.gov/fdsys/pkg/PLAW-110publ233/pdf/PLAW-110publ233. pdf〉. Accessed 3 October 2012.
27. Allain DC, Friedman S, Senter L. Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act. Fam Cancer 2012.
28. Lanie AD, Jayaratne TE, Sheldon JP, et al. Exploring the public understanding of basic genetic concepts. J Genet Couns 2004;13:305-320.
29. Centers for Disease Control and Prevention. Autism A.L.A.R.M. Guidelines. 2010 〈http://www.medicalhomeinfo.org/downloads/pdfs/AutismAlarm. pdf〉. Accessed September 8, 2012.
30. Baars MJ, Henneman L, Ten Kate LP. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genet Med 2005;7:605-610.
31. Freedman AN, Wideroff L, Olson L, et al. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet Part A 2003;120A:63-71.
32. Chen L, Zhao M, Zhou Q, Xu L. Chinese Americans' views of prenatal genetic testing in the genomic era: a qualitative study. Clin Genet 2012;82:22-27.
33. Kemper AR, Bailey DB Jr. Pediatricians' knowledge of and attitudes toward fragile X syndrome screening. Acad Pediatr 2009;9:114-117.
34. Golnik A, Ireland M, Borowsky IW. Medical homes for children with autism: a physician survey. Pediatrics 2009;123:966-971.
35. Harrington JW, Patrick PA, Edwards KS, Brand DA. Parental beliefs about autism: implications for the treating physician. Autism 2006;10:452-462.
36. Chen LS, Goodson P. Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review. Genet Med 2007;9:442-450.
37. Phillips KA, Warner E, Meschino WS, et al. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin Genet 2000;57:376-383.
38. Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 2002;6:79-87.
39. Catz DS, Green NS, Tobin JN, et al. Attitudes about genetics in underserved, culturally diverse populations. Community Genet 2005;8:161-172.
40. Hudson K, Scott J, Brauch S et al. Reprodutive Genetic Testing: What America Thinks. 2004a. 〈http://www.dnapolicy.org/pub.reports. php?action=detail&reprot-id=6〉. Accessed 8 September 2012.